Retrophin to offer shares

Retrophin (RTRX) announces a $40M public offering.

The company plans to use the proceeds "to obtain regulatory approval for the reintroduction of Syntocinon into the U.S. market," among other things. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs